BOLD
Price
$1.15
Change
+$0.01 (+0.88%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
25.3M
43 days until earnings call
PRLD
Price
$1.17
Change
+$0.14 (+13.59%)
Updated
Sep 24, 04:57 PM (EDT)
Capitalization
58.3M
55 days until earnings call
Interact to see
Advertisement

BOLD vs PRLD

Header iconBOLD vs PRLD Comparison
Open Charts BOLD vs PRLDBanner chart's image
Boundless Bio
Price$1.15
Change+$0.01 (+0.88%)
Volume$1K
Capitalization25.3M
Prelude Therapeutics
Price$1.17
Change+$0.14 (+13.59%)
Volume$133
Capitalization58.3M
BOLD vs PRLD Comparison Chart in %
Loading...
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLD vs. PRLD commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Hold and PRLD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (BOLD: $1.13 vs. PRLD: $1.03)
Brand notoriety: BOLD and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 111% vs. PRLD: 164%
Market capitalization -- BOLD: $25.3M vs. PRLD: $58.3M
BOLD [@Biotechnology] is valued at $25.3M. PRLD’s [@Biotechnology] market capitalization is $58.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whilePRLD’s FA Score has 1 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • PRLD’s FA Score: 1 green, 4 red.
According to our system of comparison, both BOLD and PRLD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 2 TA indicator(s) are bullish while PRLD’s TA Score has 6 bullish TA indicator(s).

  • BOLD’s TA Score: 2 bullish, 4 bearish.
  • PRLD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PRLD is a better buy in the short-term than BOLD.

Price Growth

BOLD (@Biotechnology) experienced а -1.74% price change this week, while PRLD (@Biotechnology) price change was -11.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

BOLD is expected to report earnings on Nov 06, 2025.

PRLD is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRLD($58.3M) has a higher market cap than BOLD($25.3M). PRLD YTD gains are higher at: -19.216 vs. BOLD (-61.034). BOLD has higher annual earnings (EBITDA): -70.2M vs. PRLD (-133.25M). BOLD has more cash in the bank: 127M vs. PRLD (73.2M). PRLD has less debt than BOLD: PRLD (17.9M) vs BOLD (49.5M). PRLD has higher revenues than BOLD: PRLD (7M) vs BOLD (0).
BOLDPRLDBOLD / PRLD
Capitalization25.3M58.3M43%
EBITDA-70.2M-133.25M53%
Gain YTD-61.034-19.216318%
P/E Ratio0.16N/A-
Revenue07M-
Total Cash127M73.2M173%
Total Debt49.5M17.9M277%
TECHNICAL ANALYSIS
Technical Analysis
BOLDPRLD
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
43%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SR78.361.45
+1.89%
Spire
CNI92.230.22
+0.24%
Canadian National Railway
ASUR8.100.01
+0.12%
Asure Software
RVP0.82-0.01
-1.25%
Retractable Technologies
EVH8.39-0.20
-2.33%
Evolent Health

BOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with KMSTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then KMSTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
N/A
KMSTF - BOLD
56%
Loosely correlated
N/A
DSGN - BOLD
39%
Loosely correlated
-5.20%
IPSC - BOLD
35%
Loosely correlated
+1.13%
RCKT - BOLD
35%
Loosely correlated
-2.52%
PRLD - BOLD
35%
Loosely correlated
+1.98%
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with ATNM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then ATNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
+1.98%
ATNM - PRLD
39%
Loosely correlated
-0.61%
FDMT - PRLD
37%
Loosely correlated
+2.84%
ZYME - PRLD
37%
Loosely correlated
-1.03%
NKTX - PRLD
36%
Loosely correlated
-2.86%
RGNX - PRLD
35%
Loosely correlated
-1.43%
More